Christopher D. Blosser

13.7k total citations · 1 hit paper
37 papers, 762 citations indexed

About

Christopher D. Blosser is a scholar working on Transplantation, Oncology and Nephrology. According to data from OpenAlex, Christopher D. Blosser has authored 37 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Transplantation, 10 papers in Oncology and 9 papers in Nephrology. Recurrent topics in Christopher D. Blosser's work include Renal Transplantation Outcomes and Treatments (21 papers), Renal Diseases and Glomerulopathies (8 papers) and Polyomavirus and related diseases (8 papers). Christopher D. Blosser is often cited by papers focused on Renal Transplantation Outcomes and Treatments (21 papers), Renal Diseases and Glomerulopathies (8 papers) and Polyomavirus and related diseases (8 papers). Christopher D. Blosser collaborates with scholars based in United States, Australia and South Africa. Christopher D. Blosser's co-authors include Laura Bukavina, Karim Bensalah, Hendrik Van Poppel, Rodolfo Montironi, Wassim Kassouf, Valeria Panebianco, Sarah P. Psutka, Ben Challacombe, Brian Shuch and Thomas J. Mitchell and has published in prestigious journals such as Blood, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Christopher D. Blosser

34 papers receiving 752 citations

Hit Papers

Epidemiology of Renal Cell Carcinoma: 2022 Update 2022 2026 2023 2024 2022 100 200 300

Peers

Christopher D. Blosser
Anna M. Leliveld Netherlands
Max Weiß Germany
Radovan Sašo United Kingdom
Michelle Rashford United States
Masato Fujiki United States
Majella B. Doyle United States
Satish Shanbhag United States
Donald F. Chute United States
David Topolsky United States
Anna M. Leliveld Netherlands
Christopher D. Blosser
Citations per year, relative to Christopher D. Blosser Christopher D. Blosser (= 1×) peers Anna M. Leliveld

Countries citing papers authored by Christopher D. Blosser

Since Specialization
Citations

This map shows the geographic impact of Christopher D. Blosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Blosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Blosser more than expected).

Fields of papers citing papers by Christopher D. Blosser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Blosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Blosser. The network helps show where Christopher D. Blosser may publish in the future.

Co-authorship network of co-authors of Christopher D. Blosser

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Blosser. A scholar is included among the top collaborators of Christopher D. Blosser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Blosser. Christopher D. Blosser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Akaike, Tomoko, Daniel S. Hippe, Matthew W. Gilmour, et al.. (2025). Merkel cell carcinoma in solid organ transplant recipients: prognosis and response to immunotherapy. British Journal of Dermatology. 193(6). 1221–1231.
3.
Engels, Eric A., Douglas A. Corley, Christopher D. Blosser, et al.. (2024). Cure models, survival probabilities, and solid organ transplantation for patients with colorectal cancer. American Journal of Transplantation. 25(3). 545–555. 1 indexed citations
4.
Hill, Joshua A., Jim Boonyaratanakornkit, Rebecca Gardner, et al.. (2023). Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy. American Journal of Transplantation. 23(3). 416–422. 10 indexed citations
5.
Boonpheng, Boonphiphop, Yue‐Harn Ng, Christopher D. Blosser, et al.. (2023). Tocilizumab for treatment of chronic active antibody‐mediated rejection in kidney transplant recipients. Clinical Transplantation. 37(5). e14936–e14936. 11 indexed citations
6.
Au, Eric, Germaine Wong, Allison Tong, et al.. (2022). Scope and Consistency of Cancer Outcomes Reported in Randomized Trials in Kidney Transplant Recipients. Kidney International Reports. 8(2). 274–281. 1 indexed citations
7.
Portuguese, Andrew J., Jordan Gauthier, Scott S. Tykodi, et al.. (2022). CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review. Bone Marrow Transplantation. 58(4). 353–359. 16 indexed citations
8.
Bukavina, Laura, Karim Bensalah, Freddie Bray, et al.. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. European Urology. 82(5). 529–542. 358 indexed citations breakdown →
9.
Blosser, Christopher D., et al.. (2022). Transplant Onconephrology: An Update. Seminars in Nephrology. 42(6). 151348–151348. 1 indexed citations
10.
Johnson, Christopher K., et al.. (2021). Monoclonal Gammopathy of Renal Significance Causes C3 Glomerulonephritis Via Monoclonal IgG Kappa Inhibition of Complement Factor H. Kidney International Reports. 6(9). 2505–2509. 6 indexed citations
11.
Butler, Catherine R., James D. Perkins, Christopher K. Johnson, et al.. (2020). Contemporary patterns in kidney graft survival from donors after circulatory death in the United States. PLoS ONE. 15(5). e0233610–e0233610. 8 indexed citations
12.
Blosser, Christopher D., Gregory Haber, & Eric A. Engels. (2020). Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period. Kidney International. 99(6). 1430–1438. 31 indexed citations
13.
Butler, Catherine R., James D. Perkins, Christopher K. Johnson, et al.. (2019). Burden of excess mortality after implementation of the new kidney allocation system may be borne disproportionately by middle-aged recipients. PLoS ONE. 14(1). e0210589–e0210589. 6 indexed citations
14.
Andeen, Nicole K., Jennifer Schleit, Christopher D. Blosser, et al.. (2017). LMX1B-Associated Nephropathy With Type III Collagen Deposition in the Glomerular and Tubular Basement Membranes. American Journal of Kidney Diseases. 72(2). 296–301. 10 indexed citations
15.
Tower, Clare, Morayma Reyes, Karen Nelson, et al.. (2016). Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection. Transplantation. 101(9). 2235–2243. 30 indexed citations
16.
Sibulesky, Lena, Nicolae Leca, Christopher D. Blosser, et al.. (2016). Is MELD score failing patients with liver disease and hepatorenal syndrome?. World Journal of Hepatology. 8(27). 1155–1155. 4 indexed citations
17.
Blosser, Christopher D., Roy D. Bloom, Simin Göral, et al.. (2011). Age, Exclusion Criteria, and Generalizability of Randomized Trials Enrolling Kidney Transplant Recipients. Transplantation. 91(8). 858–863. 36 indexed citations
18.
Rahman, Adeeb, Ruan Zhang, Christopher D. Blosser, et al.. (2011). Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88. Blood. 117(11). 3123–3130. 22 indexed citations
19.
Blosser, Christopher D. & Roy D. Bloom. (2010). Posttransplant anemia in solid organ recipients. Transplantation Reviews. 24(2). 89–98. 23 indexed citations
20.
Blosser, Christopher D., et al.. (2010). High rate of fistula placement in a cohort of dialysis patients in a single payer system. Hemodialysis International. 14(4). 393–397. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026